Pantai Premier Pathology (PPP) celebrated its 25th anniversary on 21 December 2022, with an appreciation dinner for staff and partners attended by IHH Chairman Tan Sri Mohammed Azlan and IHH Managing Director & CEO Dr Kelvin Loh.
Additionally, PPP recently announced two new collaborations with bioMérieux and MiRXES to strengthen our lab diagnostics capabilities.
Under the MOU with French biotech MNC bioMérieux, PPP will set up an Antimicrobial Stewardship Centre of Excellence to promote the responsible use of antibiotics and preserve the efficacy of these drugs for the present and future generations. PPP plays a crucial role in supporting the efforts to contain antimicrobial resistance by identifying the pathogen responsible for a patient's infection and conducting antimicrobial susceptibility testing to determine the optimal antimicrobial therapy for the patient.
The collaboration with MiRXES seeks to provide accessible and affordable molecular oncology testing to Malaysians which includes the early detection of gastric cancer via blood test and DNA testing.
These partnerships are critical towards providing our patients with the best care and clinical outcomes. We look forward to further serving our communities through these partnerships.
Congratulations to the PPP team on its Silver Jubilee and the two MOUs!
Related Stories
Future of Work: AI Agents in Action Hackathon Highlights AI Solutions for Healthcare and Business Challenges
The Future of Work: AI Agents in Action Hackathon invited colleagues from across the IHH network to explore how AI agents can help solve everyday challenges in healthcare and business operations.
Gleneagles Hong Kong Champions Health and Wellness at Hong Kong Cyclothon
IHH Healthcare's Gleneagles Hospital Hong Kong supported the 2026 Hong Kong Cyclothon as the event's Official Wellness Partner, helping promote active living and community wellbeing while providing medical support for one of the city's largest mass participation sporting events.
Pantai Hospital Kuala Lumpur Completes First Iberis® RDN Transradial Procedure Across Pantai Hospitals Group
Pantai Hospital Kuala Lumpur has achieved a cardiovascular care milestone with the successful completion of the first Iberis® renal denervation (RDN) transradial procedure within the Pantai hospital network.
Fortis Expands Advanced Respiratory Care with Dedicated Lung Failure Clinics
Fortis Healthcare, part of IHH Healthcare, is strengthening respiratory and transplant care in Delhi through new multidisciplinary Lung Failure Clinics.
Acibadem Advances Cancer Care with Türkiye’s First Private Proton Therapy Programme
Acibadem Healthcare Group, part of IHH Healthcare, is introducing cutting-edge proton therapy in Istanbul to deliver more precise, patient-centred cancer treatment and strengthen regional oncology expertise.
IHH Healthcare Wins Four Awards for Leadership and Learning Excellence
IHH Healthcare has been recognised at the 2026 HCM Excellence Awards® by Brandon Hall Group™ for four innovative programmes in leadership and learning. The awards showcase our commitment to strengthening capability, fostering collaboration and advancing a culture of safety and integrity across its global network.
